SCHEDULE 13D

Company

Armata Pharmaceuticals, Inc.

Filed

February 14, 2020

Accession Number

0000899140-20-000160

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →